Kazuma Fujita
Hondo, 0108543, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Relationship of nutritional or systemic inflammatory markers with efficacy of gemcitabine and cisplatin with or without durvalumab therapy for patients with unresectable or metastatic biliary tract cancer: a retrospective study.
Journal: Journal of pharmaceutical health care and sciences
Published: August 31, 2025
Effects of the Japanese Kampo Medicines Rikkunshito, Shakuyakukanzoto and Goreisan on Lenvatinib Plasma Concentrations in Japanese Patients with Thyroid Cancer.
Journal: Drugs - real world outcomes
Published: November 10, 2024
Predictive factors for first dose reduction and interruption of lenvatinib after beginning of the standard dose in Japanese patients with thyroid cancer.
Journal: Cancer chemotherapy and pharmacology
Published: July 05, 2024
Association of the modified Glasgow prognostic score and prognostic nutritional index with duration of oral anamorelin administration in patients with cancer cachexia: a retrospective cohort study.
Journal: Japanese journal of clinical oncology
Published: April 18, 2024
Association between albumin-bilirubin grade and plasma trough concentrations of regorafenib and its metabolites M-2 and M-5 at steady-state in Japanese patients.
Journal: Investigational new drugs
Published: January 09, 2024
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.
Journal: Frontiers in cell and developmental biology
Published: October 20, 2023
A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma.
Journal: Anticancer research
Published: October 04, 2022
Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: May 25, 2021
Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy.
Journal: Medical oncology (Northwood, London, England)
Published: June 03, 2020
Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities.
Journal: International journal of clinical oncology
Published: August 12, 2019
Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer.
Journal: Scientific reports
Published: November 20, 2018
Quantitative determination of regorafenib and its two major metabolites in human plasma with high-performance liquid chromatography and ultraviolet detection.
Journal: Biomedical chromatography : BMC
Published: January 21, 2016
Last Updated: 09/26/2026